Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03107520 · ClinicalTrials.gov registry record · Early Phase 1
Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH
A Early Phase 1 study of Developmental Dysplasia of the Hip, sponsored by Children's Hospital of Philadelphia.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 125
- Enrollment target
- 1
- Study location
NCT03107520 is a Early Phase 1 study of Developmental Dysplasia of the Hip that is actively recruiting participants, run by Children's Hospital of Philadelphia. The registered enrollment target is 125 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03107520, a Early Phase 1 study of Developmental Dysplasia of the Hip, is actively recruiting participants, sponsored by Children's Hospital of Philadelphia.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates the feasibility and utility of contrast-enhanced ultrasound to provide real-time assessment of blood flow to the femoral head in infants undergoing surgical reduction for developmental dysplasia of the hip.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Intraoperative contrast-enhanced ultrasound (CEUS)
- DRUG Lumason
Study Locations (1)
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2017-05-22 |
| Est. Completion | 2030-04 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03107520
The ClinicalTrials.gov registry entry for NCT03107520 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Developmental Dysplasia of the Hip appearing as the primary indexed condition, and to 2 interventions - of which Intraoperative contrast-enhanced ultrasound (CEUS) is the first listed.
NCT03107520 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03107520 about?
NCT03107520 is a clinical study titled "Intraoperative Contrast-Enhanced Ultrasound Evaluation of Blood Flow at the Time of Surgical Hip Reduction for DDH". This study evaluates the feasibility and utility of contrast-enhanced ultrasound to provide real-time assessment of blood flow to the femoral head in infants undergoing surgical reduction for developmental dysplasia of the hip.
What is the current status of trial NCT03107520?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 125 participants. The study started on 2017-05-22. Estimated completion is 2030-04.
What conditions does trial NCT03107520 study?
This clinical trial studies the following conditions: Developmental Dysplasia of the Hip.
What interventions are being tested in trial NCT03107520?
The interventions under investigation include: Intraoperative contrast-enhanced ultrasound (CEUS) (DIAGNOSTIC_TEST), Lumason (DRUG).
Who is sponsoring clinical trial NCT03107520?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03107520 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.